Information
-
Trademark
-
79324985
-
Serial Number
79324985
-
Registration Number
6966095
-
International Classifications
-
Filing Date
July 06, 2021
3 years ago
-
Registration Date
January 31, 2023
2 years ago
-
Transaction Date
May 30, 2023
a year ago
-
Status Date
January 31, 2023
2 years ago
-
Published for Opposition Date
November 15, 2022
2 years ago
-
Location Date
January 31, 2023
2 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KEELEY, ALISON REBECCA
-
Attorney Docket Number
28193/65
Attorney Name
Max Vern
Law Office Assigned Location Code
M40
-
Owners
Case File Statements
- DM0000: The mark consists of the stylized design of an X-shaped chromosome at an angle, appearing inside the outline of a circle.
- GS0441: Medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; healthcare; health counselling; providing health information in the field of health assessment services; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; telemedicine services, not including dentistry services; medical testing services, namely, medical diagnostic testing; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; genetic testing for medical purposes; medical equipment rental; providing collected and managed medical information and personal health information; providing health information services, not including dentistry services; health care business through the Internet, namely, providing online healthcare services; health management consulting business through the Internet namely, providing online healthcare services; healthcare services through the Internet; clinical test in the nature of diagnostic testing and genetic testing for medical treatment purposes and information services related thereto; clinical pathology examination in the nature of medical examination services; medical cancer testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; health center services; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; performing diagnosis of diseases; pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
- GS0421: Research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological services, namely, testing and analysis of biological samples in research laboratories; biological research; crude drugs research; biochemical analysis; biochemical research; research and development in the field of special testing using genetic engineering; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; engineering surveying; technology project research in the field of medical and diagnostic testing; technological research in the field of medical and diagnostic testing; research and development of new products for others; research and development of vaccines and medicines; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical research in relation to diagnostic testing for identifying hereditary risk factors; medical research in relation to diagnostic testing for evaluating clinical trial progress; medical research in relation to diagnostic testing for preventing illness; medical research in relation to diagnostic testing services; medical research in relation to diagnostic testing services for predicting disease; testing of pharmaceuticals; pharmaceutical research; medical research; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others
Case File Event Statements
-
5/30/2023 - a year ago
28 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
5/4/2023 - a year ago
27 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
5/4/2023 - a year ago
26 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
4/30/2023 - a year ago
25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
1/31/2023 - 2 years ago
24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
1/31/2023 - 2 years ago
23 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
11/15/2022 - 2 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
11/15/2022 - 2 years ago
21 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/26/2022 - 2 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/10/2022 - 2 years ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/10/2022 - 2 years ago
18 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
10/10/2022 - 2 years ago
17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
10/10/2022 - 2 years ago
16 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
10/10/2022 - 2 years ago
15 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
10/3/2022 - 2 years ago
14 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
10/3/2022 - 2 years ago
13 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
9/9/2022 - 2 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/9/2022 - 2 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/9/2022 - 2 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/6/2022 - 2 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
5/17/2022 - 2 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
5/17/2022 - 2 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
4/1/2022 - 3 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
3/31/2022 - 3 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/25/2022 - 3 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/12/2021 - 3 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
11/8/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/4/2021 - 3 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR